Hims & Hers Health continues to drive impressive growth through its subscription-based consumer wellness platform. Teladoc Health maintains a dominant market share with over 100 million global members and significant institutional partnerships.

NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.

Teladoc's business is slowly improving due to several initiatives. However, the company still faces potential headwinds that could derail its progress.

The latest trading day saw Teladoc (TDOC) settling at $8.48, representing a -2.42% change from its previous close.

Teladoc (TDOC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Veteran enterprise sales executive brings decades of experience scaling companies and leading successful commercial organizations SURPRISE, Ariz., June 29, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control solutions for managing rodent populations, today announced the appointment of Jack Karabees as Executive Vice President of Sales.

Teladoc (TDOC) concluded the recent trading session at $7.81, signifying a +1.56% move from its prior day's close.

The GLP-1 revolution is quietly continuing even as investor interest has moved on to more timely topics. One of the best ways to access the fast-growing weight loss drug space is via makers like Novo Nordisk NYSE: NVO or Eli Lilly NYSE: LLY, the leading companies responsible for developing and manufacturing products like Ozempic and Zepbound.

Teladoc (TDOC) reached $7.57 at the closing of the latest trading day, reflecting a +1.47% change compared to its last close.

Teladoc (TDOC) reached $7.03 at the closing of the latest trading day, reflecting a +1.44% change compared to its last close.